Bing Center for Waldenström's Macroglobulinemia

Clinical Trials Questions?


The Bing Center for Waldenström's Macroglobulinemia (WM) is the largest center in the world dedicated to the study and development of new, targeted treatments for WM and related Immunoglobulin M (IgM) disorders, including IgM-related neuropathy and Bing Neel syndrome. The Center is credited with the approval of the first-ever drug for WM (ibrutinib), the advancement of many new drugs for WM through clinical trials, and the discovery of the MYD88 and CXCR4 mutations which are critical in WM.

The Bing Center for Waldenström's Macroglobulinemia provides a comprehensive range of services for patients with Waldenström's macroglobulinemia, including:

  • Evaluations and ongoing clinical care
  • Consultations (second opinions)
  • Genomic testing for relevant mutations including MYD88, CXCR4, and TP53
  • Pathology review of biopsy samples
  • A personalized treatment plan offering the latest therapies
  • Access to clinical trials offering novel treatments
  • Participation in research studies of WM genomics and new drug discovery
  • Complementary therapies through the Leonard P. Zakim Center for Integrative Therapies and Healthy Living

Services and Support at Dana-Farber


Becoming Our Patient

As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.


Support Services and Amenities

We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.


How Our Patients Rate Dana-Farber

See patient satisfaction survey results for different Dana-Farber locations collected by Press Ganey, an independent company experienced in patient satisfaction surveying.


Eating Well During Cancer Video Series

This video series and resource toolkit features Dana-Farber nutrition specialist Stacy Kennedy, MPH, RD, CSO, LDN, and explores how diet can help support your health and well-being during and after cancer treatment.